2005 News Archive

Morphotek Announces Collaboration With The John Wayne Cancer Institute For The Development Of Antibodies To Treat Melanoma And Lung Cancer

November 14, 2005

Exton, PA, November 14, 2005 – Morphotek® Inc. announced today that it has entered into a collaboration with the John Wayne Cancer...

+ Read the Article

Morphotek Announces Grant Award From DARPA To Develop Cell Lines For Scalable Manufacturing Of Anti-Biowarfare Agents

September 15, 2005

Exton, PA, September 15, 2005 -- Morphotek® Inc. announced today that it has been awarded a grant from the Defense Advanced Research...

+ Read the Article

Morphotek Issued U.S. Patent 6,921,666 for Generating Genetically Evolved Yeast Through the Regulation of Mismatch Repair

August 8, 2005

Morphotek®, Inc. announced today the issuance of United States Patent 6,921,666 covering the regulation of mismatch...

+ Read the Article

Morphotek and Baxter Extend Development and Clinical Supply Agreement to Support Morphotek's Antibody Pipeline

June 30, 2005

Morphotek, Inc. announced today that it has broadened its manufacturing supply agreement with Baxter Healthcare Corporation to support the...

+ Read the Article

Morphotek Announces Multi-Project, Research, Evaluation and Collaboration Agreement with GlaxoSmithKline

May 18, 2005

Morphotek Inc. today announced that it has entered into a Research, Evaluation and Collaboration Agreement with GlaxoSmithKline to apply Morphotek's...

+ Read the Article

Morphotek Announces Multi-Year, Research Collaboration Agreement with Amgen to Optimize Expression of Antibodies

April 18, 2005

Morphotek Inc. today announced that it has entered into a multi-year Research Collaboration Agreement with Amgen Inc. to apply Morphotek's...

+ Read the Article

Morphotek Announces Acceptance of Investigational New Drug Application for MORAb-003, a humanized monoclonal antibody for the treatment of advanced ovarian cancer

March 28, 2005

Morphotek Inc. announced that the United States Food and Drug Administration has accepted its Investigational New Drug (IND) Application for...

+ Read the Article

William Claypool joins Morphotek Board of Directors

March 9, 2005

Morphotek Inc. announced today that William D. Claypool, MD, has been appointed to its Board of Directors "We are delighted to welcome a person with...

+ Read the Article

Morphotek Receives NCI Funding to Support Development of High Throughput Antibody Dependent Cellular Cytotoxicity Assays to Generate Therapeutic Antibodies

January 31, 2005

Morphotek Inc. announced today that it has been awarded a Developmental Project grant from the Network for Translational Research in Optical Imaging...

+ Read the Article

Go to Page: 1

Results per page 10 25 50